Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Phase 1
Recruiting
Conditions
ALL, Childhood
MDS
AML, Childhood
Hematologic Malignancy
Lymphoma
Interventions
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: CD70-CAR T cell infusion (Autologous)
Drug: Mesna
Subscribe
First Posted Date
2024-03-22
Last Posted Date
2024-12-17
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
24
Registration Number
NCT06326463
Locations
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy